Health Risk Assessment System

A personalised and precise monitoring system integrating exposome-based data from users, environmental sensors, and wearables to estimate an individual’s risk of developing cardiovascular and metabolic diseases.

A prototype of the system is being developed and tested during the project to assess its feasibility, usability, and acceptability. The system comprises three core parts:

  • A smartphone app for the user to enter exposome data (e.g., sleep habits, dietary intake), wearables (e.g., a Fitbit) and an online database and dashboard to store and display the users’ exposome data and associated disease risk.
  • An environmental hub and remote sensors to gather exposure data (e.g., air quality) which securely interfaces with the online database.
  • An Artificial Intelligence based predictive model which extracts and uses data from the online database to determine disease risk.

This novel system will enable the longitudinal monitoring of lifestyle and environmental exposure data, providing health risk assessments for use by the individual users and/or third parties such as researchers and healthcare professionals. Access to the prototype system will be restricted to project partners.

Read more about the Health Risk Assessment System.

Timescale for completion: Winter 2024


Description of TRL levels

  • TRL 1 – Basic principles observed
  • TRL 2 – Technology concept formulated
  • TRL 3 – Experimental proof of concept
  • TRL 4 – Technology validated in lab
  • TRL 5 – Technology validated in relevant environment
  • TRL 6 – Technology demonstrated in relevant environment
  • TRL 7 – System prototype demonstration in operational environment
  • TRL 8 – System complete and qualified
  • TRL 9 – Actual system proven in operational environment


Prototype testing commenced

User testing of the prototype Health Risk Assessment System has now commenced; results will be available in Spring 2024.

Prototype testing

Set up and installation of the prototype system, in 15 users homes in Italy, will begin in September 2023. This small scale testing will run, as soon as installation is complete, until March 2024.